Literature DB >> 28116655

Synthesis and characterization of chitosan-grafted-polycaprolactone micelles for modulate intestinal paclitaxel delivery.

Andreia Almeida1, Daniella Silva2, Virginia Gonçalves3, Bruno Sarmento4,5.   

Abstract

In this work, self-assembled amphiphilic micelles based on chitosan (CS) and polycaprolactone (PCL) were produced and used as carriers of paclitaxel (PTX) to improve its intestinal pharmacokinetic profile. Chitosan-grafted-polycaprolactone (CS-g-PCL) was synthesized through a carbodiimide reaction by amidation and confirmed by Fourier transform infrared spectroscopy (FTIR), hydrogen nuclear magnetic resonance analysis (1H NMR), and contact angle evaluation. Micelles were produced by solvent evaporation method, and the critical micelle concentration was investigated by conductimetry. The obtained micelles were of 408-nm mean particle size, narrow size distribution (polydispersity index of 0.335) and presented positive surface charge around 30 mV. The morphology of micelles assessed by transmission electron microscopy (TEM) revealed round and smooth surface, in agreement with dynamic light scattering measurements. The association efficiency determined by high-performance liquid chromatography (HPLC) was as high as 82%. The in vitro cytotoxicity of the unloaded and PTX-loaded micelles was tested against Caco-2 and HT29-MTX intestinal epithelial cells, resulting in the absence of cell toxicity for all formulations. Moreover, the permeability of PTX-loaded micelles in Caco-2 monolayer and Caco-2/HT29-MTX co-culture model was determined. Results showed that the permeability of PTX was higher in Caco-2/HT29-MTX co-culture model compared with Caco-2 monolayer due to the mucoadhesive character of micelles, acting as a platform to deliver PTX at the sites of absorption. Therefore, it can be concluded that the PTX-loaded CS-g-PCL micelles, employed for the first time as PTX carriers, may be a potential drug carrier for the intestinal delivery of hydrophobic drugs, particularly anticancer agents.

Entities:  

Keywords:  Chitosan; Drug delivery; Micelles; Paclitaxel; Polycaprolactone

Mesh:

Substances:

Year:  2018        PMID: 28116655     DOI: 10.1007/s13346-017-0357-8

Source DB:  PubMed          Journal:  Drug Deliv Transl Res        ISSN: 2190-393X            Impact factor:   4.617


  37 in total

1.  Development and characterization of crosslinked hyaluronic acid polymeric films for use in coating processes.

Authors:  Débora Sgorla; Andreia Almeida; Claudia Azevedo; Ÿlcio Jose Bunhak; Bruno Sarmento; Osvaldo Albuquerque Cavalcanti
Journal:  Int J Pharm       Date:  2016-07-18       Impact factor: 5.875

2.  Shell cross-linked stearic acid grafted chitosan oligosaccharide self-aggregated micelles for controlled release of paclitaxel.

Authors:  Fu-Qiang Hu; Guo-Fei Ren; Hong Yuan; Yong-Zhong Du; Su Zeng
Journal:  Colloids Surf B Biointerfaces       Date:  2006-05-05       Impact factor: 5.268

3.  Towards the characterization of an in vitro triple co-culture intestine cell model for permeability studies.

Authors:  Francisca Araújo; Bruno Sarmento
Journal:  Int J Pharm       Date:  2013-10-10       Impact factor: 5.875

4.  Establishment of a triple co-culture in vitro cell models to study intestinal absorption of peptide drugs.

Authors:  Filipa Antunes; Fernanda Andrade; Francisca Araújo; Domingos Ferreira; Bruno Sarmento
Journal:  Eur J Pharm Biopharm       Date:  2012-11-16       Impact factor: 5.571

5.  The mechanism of enhancement on oral absorption of paclitaxel by N-octyl-O-sulfate chitosan micelles.

Authors:  Ran Mo; Xiang Jin; Nan Li; Caoyun Ju; Minjie Sun; Can Zhang; Qineng Ping
Journal:  Biomaterials       Date:  2011-03-26       Impact factor: 12.479

6.  Paclitaxel-loaded polymeric micelles based on poly(ɛ-caprolactone)-poly(ethylene glycol)-poly(ɛ-caprolactone) triblock copolymers: in vitro and in vivo evaluation.

Authors:  Linhua Zhang; Yingna He; Guilei Ma; Cunxian Song; Hongfan Sun
Journal:  Nanomedicine       Date:  2011-11-17       Impact factor: 5.307

7.  Synthesis and characterization of the biodegradable polycaprolactone-graft-chitosan amphiphilic copolymers.

Authors:  Haijun Yu; Wenshou Wang; Xuesi Chen; Chao Deng; Xiabin Jing
Journal:  Biopolymers       Date:  2006-10-15       Impact factor: 2.505

8.  FTIR study of polycaprolactone chain organization at interfaces.

Authors:  Tamara Elzein; Mohamad Nasser-Eddine; Christelle Delaite; Sophie Bistac; Philippe Dumas
Journal:  J Colloid Interface Sci       Date:  2004-05-15       Impact factor: 8.128

9.  Correlation between oral drug absorption in humans, and apparent drug permeability in TC-7 cells, a human epithelial intestinal cell line: comparison with the parental Caco-2 cell line.

Authors:  M C Grès; B Julian; M Bourrié; V Meunier; C Roques; M Berger; X Boulenc; Y Berger; G Fabre
Journal:  Pharm Res       Date:  1998-05       Impact factor: 4.200

10.  Hydrophobically modified inulin as an amphiphilic carbohydrate polymer for micellar delivery of paclitaxel for intravenous route.

Authors:  Pratik Muley; Sunny Kumar; Fadoua El Kourati; Siddharth S Kesharwani; Hemachand Tummala
Journal:  Int J Pharm       Date:  2016-01-11       Impact factor: 5.875

View more
  5 in total

1.  Graphene oxide (GO)-based nanosheets with combined chemo/photothermal/photodynamic therapy to overcome gastric cancer (GC) paclitaxel resistance by reducing mitochondria-derived adenosine-triphosphate (ATP).

Authors:  Weihong Guo; Zhian Chen; Xiaoli Feng; Guodong Shen; Huilin Huang; Yanrui Liang; Bingxia Zhao; Guoxin Li; Yanfeng Hu
Journal:  J Nanobiotechnology       Date:  2021-05-19       Impact factor: 10.435

2.  Novel drug delivery systems, devices, and fabrication methods.

Authors:  Vivek Agrahari
Journal:  Drug Deliv Transl Res       Date:  2018-04       Impact factor: 4.617

3.  pH- and Ultrasound-Responsive Paclitaxel-Loaded Carboxymethyl Chitosan Nanodroplets for Combined Imaging and Synergistic Chemoradiotherapy.

Authors:  Mengmeng Shang; Xiao Sun; Lu Guo; Dandan Shi; Ping Liang; Dong Meng; Xiaoying Zhou; Xinxin Liu; Yading Zhao; Jie Li
Journal:  Int J Nanomedicine       Date:  2020-01-24

4.  N-(2-Hydroxy)-propyl-3-trimethylammonium, O-Mysristoyl Chitosan Enhances the Solubility and Intestinal Permeability of Anticancer Curcumin.

Authors:  Daniella S Silva; Danilo M Dos Santos; Andreia Almeida; Leonardo Marchiori; Sérgio P Campana-Filho; Sidney J L Ribeiro; Bruno Sarmento
Journal:  Pharmaceutics       Date:  2018-11-20       Impact factor: 6.321

5.  An overview of chitosan and its application in infectious diseases.

Authors:  Qingye Meng; Ying Sun; Hailin Cong; Hao Hu; Fu-Jian Xu
Journal:  Drug Deliv Transl Res       Date:  2021-01-26       Impact factor: 4.617

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.